Shanghai Shen Lian Biomedical Corporation (SHA:688098)

Market Cap	3.23B +43.9%
Revenue (ttm)	272.12M -7.5%
Net Income	-19.21M
EPS	n/a
Shares Out	410.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,918,517
Open	8.03
Previous Close	8.01
Day's Range	7.82 - 8.03
52-Week Range	5.70 - 17.57
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:688098

Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 374
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688098

Financial Performance

In 2025, SHA:688098's revenue was 288.27 million, a decrease of -4.99% compared to the previous year's 303.41 million. Losses were -20.50 million, -54.19% less than in 2024.